US5288723027
US5288723027
Lexicon Pharmaceuticals, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 49.803.000 | 31.081.000 | 60.2% |
| Cost of Revenue | 274.000 | 616.000 | 55.5% |
| Gross Profit | 49.529.000 | 30.465.000 | 62.6% |
| 98.440.000 | 227.582.000 | 56.7% | |
| Operating Income | -48.911.000 | -197.117.000 | 75.2% |
| Pretax Income | -50.341.000 | -200.403.000 | 74.9% |
| Net Income Common Stockholders | -50.341.000 | -200.403.000 | 74.9% |
| -- | -- | -- | |
| -- | -- | -- |